Skip to main content
. 2022 Sep 13;149(8):4347–4358. doi: 10.1007/s00432-022-04330-5

Fig. 1.

Fig. 1

A Putative CD44pos/CD24neg phenotype negative for CD71, B an irregular and viable CD44+ cells allegedly associated with malignancy with a morphological index greater 35, and C a classic late erythroblast with CD71pos/CD44neg phenotype